CMAUP Plant Collective Molecular Activities

Plant Name: Prunus persica

Taxonomic Information:

Plant ID: NPO14992
Plant Latin Name: Prunus persica
Taxonomy Genus: Prunus
Taxonomy Family: Rosaceae

Plant External Links:

NCBI TaxonomyDB: 3760
Plant-of-the-World-Online: n.a.

Used in Medicines:

Country/Region:

Turkey; China; India

Traditional Medicine System:

Sowa-Rigpa; Unani; Ayurveda; Kampo; TCM; Homeopathy

Medicinal Functions:

Alterative; Anthelmintic; Antiasthmatic; Antihalitosis; Antitussive; Astringent; Demulcent; Diuretic; Emollient; Expectorant; Febrifuge; Haemolytic; Laxative; Sedative

Geographical Distribution:

Turkey; India; China

Example Image

Geographical Distribution

See the Plant Occurrence Worldwide with Latitude and Longitude Available

Collective Molecular Activities of the Plant

List of Human Proteins Collectively Targeted by the Plant

Target Activity Range: ≤ 1μM
Click Gene ID to Access Activity Profile of Individual Target

Target Class	Target Proteins
Small molecule receptor (family A GPCR)	FFAR4; FFAR1;
Peptide receptor (family A GPCR)	TSHR;
Lyase	CA7; CA4;
Nuclear hormone receptor subfamily 1 group C	PPARA;
Enzyme_unclassified	ALOX12; ALOX15; CBR1; USP2; APEX1;
Oxidoreductase	XDH;
Unclassified	FABP3; LMNA; FABP5;

List of Human Cytochrome P450 Enzymes Affected by the Plant

Activity Range: ≤ 1μM
Click Gene ID to Access Activity Profile of Individual Enzyme

Cytochrome P450 Enzymes:	CYP1B1; CYP1A1; CYP1A2; CYP19A1; CYP2C19;

Detailed Information of Target Proteins

Protein Class	Gene ID	Protein Name	Uniprot ID	Target ChEMBL ID
Cytochrome P450 family 1	CYP1B1	Cytochrome P450 1B1	Q16678	CHEMBL4878
Cytochrome P450 family 1	CYP1A1	Cytochrome P450 1A1	P04798	CHEMBL2231
Cytochrome P450 family 1	CYP1A2	Cytochrome P450 1A2	P05177	CHEMBL3356
Cytochrome P450 family 19	CYP19A1	Cytochrome P450 19A1	P11511	CHEMBL1978
Cytochrome P450 family 2	CYP2C19	Cytochrome P450 2C19	P33261	CHEMBL3622
Enzyme_unclassified	ALOX12	Arachidonate 12-lipoxygenase	P18054	CHEMBL3687
Enzyme_unclassified	ALOX15	Arachidonate 15-lipoxygenase	P16050	CHEMBL2903
Enzyme_unclassified	CBR1	Carbonyl reductase [NADPH] 1	P16152	CHEMBL5586
Enzyme_unclassified	USP2	Ubiquitin carboxyl-terminal hydrolase 2	O75604	CHEMBL1293227
Enzyme_unclassified	APEX1	DNA-(apurinic or apyrimidinic site) lyase	P27695	CHEMBL5619
Lyase	CA7	Carbonic anhydrase VII	P43166	CHEMBL2326
Lyase	CA4	Carbonic anhydrase IV	P22748	CHEMBL3729
Nuclear hormone receptor subfamily 1 group C	PPARA	Peroxisome proliferator-activated receptor alpha	Q07869	CHEMBL239
Oxidoreductase	XDH	Xanthine dehydrogenase	P47989	CHEMBL1929
Peptide receptor (family A GPCR)	TSHR	Thyroid stimulating hormone receptor	P16473	CHEMBL1963
Small molecule receptor (family A GPCR)	FFAR4	G-protein coupled receptor 120	Q5NUL3	CHEMBL5339
Small molecule receptor (family A GPCR)	FFAR1	Free fatty acid receptor 1	O14842	CHEMBL4422
Unclassified	FABP3	Fatty acid binding protein muscle	P05413	CHEMBL3344
Unclassified	LMNA	Prelamin-A/C	P02545	CHEMBL1293235
Unclassified	FABP5	Fatty acid binding protein epidermal	Q01469	CHEMBL3674

Enrichment of Gene Ontology of Target Proteins (Activity≤1μM)

Detailed Information of Enriched Gene Ontolgy

GO Type	GO Category	Enriched GO Terms	p-Value	Adjusted p-Value	Enriched Genes
MF	GO:0005488; binding	GO:0005506; iron ion binding	2.151E-12	2.342E-08	ALOX12, ALOX15, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH
BP	GO:0008152; metabolic process	GO:0097267; omega-hydroxylase P450 pathway	1.748E-10	4.757E-07	CYP1A1, CYP1A2, CYP1B1, CYP2C19
MF	GO:0005488; binding	GO:0019825; oxygen binding	8.241E-10	1.629E-06	CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19
BP	GO:0008152; metabolic process	GO:0019373; epoxygenase P450 pathway	4.945E-09	7.538E-06	CYP1A1, CYP1A2, CYP1B1, CYP2C19
BP	GO:0008152; metabolic process	GO:0055114; oxidation-reduction process	5.422E-09	7.538E-06	ALOX12, ALOX15, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH
MF	GO:0003824; catalytic activity	GO:0070330; aromatase activity	7.306E-09	9.358E-06	CYP19A1, CYP1A1, CYP1A2, CYP1B1
MF	GO:0005488; binding	GO:0020037; heme binding	1.691E-07	1.601E-04	CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19
BP	GO:0008152; metabolic process	GO:2001303; lipoxin A4 biosynthetic process	1.019E-06	7.393E-04	ALOX12, ALOX15
MF	GO:0003824; catalytic activity	GO:0047977; hepoxilin-epoxide hydrolase activity	1.019E-06	7.393E-04	ALOX12, ALOX15
BP	GO:0008152; metabolic process	GO:0009404; toxin metabolic process	1.659E-06	1.165E-03	CYP1A1, CYP1A2, CYP1B1
MF	GO:0005488; binding	GO:0005504; fatty acid binding	2.733E-06	1.750E-03	FABP3, FABP5, FFAR4
MF	GO:0003824; catalytic activity	GO:0004052; arachidonate 12-lipoxygenase activity	3.054E-06	1.797E-03	ALOX12, ALOX15
MF	GO:0003824; catalytic activity	GO:0051120; hepoxilin A3 synthase activity	3.054E-06	1.797E-03	ALOX12, ALOX15
BP	GO:0008152; metabolic process	GO:0008202; steroid metabolic process	4.351E-06	2.369E-03	CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19
MF	GO:0003824; catalytic activity	GO:0008395; steroid hydroxylase activity	5.565E-06	2.885E-03	CYP19A1, CYP1A1, CYP2C19
BP	GO:0008152; metabolic process	GO:0018894; dibenzo-p-dioxin metabolic process	6.104E-06	3.021E-03	CYP1A1, CYP1A2
BP	GO:0008152; metabolic process	GO:0016042; lipid catabolic process	6.714E-06	3.227E-03	CYP19A1, CYP1A2, CYP1B1, FABP3, FABP5
BP	GO:0008152; metabolic process	GO:0051122; hepoxilin biosynthetic process	1.017E-05	4.341E-03	ALOX12, ALOX15
BP	GO:0008152; metabolic process	GO:0016098; monoterpenoid metabolic process	1.524E-05	6.145E-03	CYP1A2, CYP2C19

Enriched KEGG Pathways of Target Proteins (Activity≤1μM)

Top 10 KEGG Pathways (ordered by adjusted p-value)

Detailed Information of Enriched KEGG Pathways

Pathway Category Top Level	Pathway Category Second Level	Pathway ID	Pathway Name	p-Value	Adjusted p-Value	Enriched Genes
09160 Human Diseases	09161 Cancers	hsa05204	Chemical carcinogenesis	1.512E-08	5.445E-07	CBR1, CYP1A2, CYP1A1, CYP1B1, CYP2C19
09100 Metabolism	09103 Lipid metabolism	hsa00590	Arachidonic acid metabolism	3.907E-07	4.689E-06	CBR1, ALOX15, ALOX12, CYP2C19
09100 Metabolism	09103 Lipid metabolism	hsa00140	Steroid hormone biosynthesis	2.979E-07	4.689E-06	CYP1A2, CYP1A1, CYP1B1, CYP19A1
09100 Metabolism	09111 Xenobiotics biodegradation and metabolism	hsa00980	Metabolism of xenobiotics by cytochrome P450	7.570E-07	6.813E-06	CBR1, CYP1A2, CYP1A1, CYP1B1
Unclassified	Unclassified	hsa01100	Metabolic pathways	1.365E-05	6.143E-05	CBR1, CYP1A2, ALOX15, CYP1A1, ALOX12, CYP2C19, CYP19A1, XDH
09100 Metabolism	09105 Amino acid metabolism	hsa00380	Tryptophan metabolism	8.252E-06	4.877E-05	CYP1A2, CYP1A1, CYP1B1
09100 Metabolism	09103 Lipid metabolism	hsa00591	Linoleic acid metabolism	3.073E-06	2.213E-05	CYP1A2, ALOX15, CYP2C19
09150 Organismal Systems	09152 Endocrine system	hsa04913	Ovarian steroidogenesis	1.627E-05	6.506E-05	CYP1A1, CYP1B1, CYP19A1
09150 Organismal Systems	09152 Endocrine system	hsa03320	PPAR signaling pathway	4.296E-05	1.546E-04	FABP3, FABP5, PPARA
09150 Organismal Systems	09156 Nervous system	hsa04726	Serotonergic synapse	1.818E-04	5.454E-04	ALOX15, ALOX12, CYP2C19
09100 Metabolism	09108 Metabolism of cofactors and vitamins	hsa00830	Retinol metabolism	1.903E-03	5.269E-03	CYP1A2, CYP1A1
09100 Metabolism	09111 Xenobiotics biodegradation and metabolism	hsa00982	Drug metabolism - cytochrome P450	2.141E-03	5.506E-03	CYP1A2, CYP2C19
09100 Metabolism	09102 Energy metabolism	hsa00910	Nitrogen metabolism	1.280E-04	4.191E-04	CA4, CA7
09100 Metabolism	09110 Biosynthesis of other secondary metabolites	hsa00232	Caffeine metabolism	9.483E-06	4.877E-05	CYP1A2, XDH

Human Diseases Associated with the Target Proteins of the Plant

Detailed Information of Human Diseases

ICD10 Disease Category	Disease Name	ICD10 Code	Associated Disease Targets (Association Ref: TTD database)
M00-M99: Diseases of the musculoskeletal system and connective tissue	Gout	M10	XDH;
C00-D49: Neoplasms	Advanced breast cancer	C50	CYP19A1;
C00-D49: Neoplasms	Breast cancer	C50	CYP19A1;
C00-D49: Neoplasms	Bladder cancer	C67	CYP19A1;
E00-E89: Endocrine, nutritional and metabolic diseases	Diabetes	E23.2, N25.1	FFAR1;
H00-H59: Diseases of the eye and adnexa	Ocular hypertension	H40.0	CA4;
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure	Diagnostic test to differentiate primary and secondary hypothyroidism	W88	TSHR;
J00-J99: Diseases of the respiratory system	Asthma	J45	CBR1;
C00-D49: Neoplasms	Thyroid cancer	C73	TSHR;
E00-E89: Endocrine, nutritional and metabolic diseases	Hyperuricaemia in gout	E79.0, M10	XDH;
C00-D49: Neoplasms	Ocular cancer	C69	APEX1;
H00-H59: Diseases of the eye and adnexa	Open-angle glaucoma	H40-H42	CA4;
I00-I99: Diseases of the circulatory system	Heart failure	I50	XDH;
E00-E89: Endocrine, nutritional and metabolic diseases	Type 2 diabetes	E11	FFAR1;
C00-D49: Neoplasms	Thyroid cancer diagnosis	C73	TSHR;
G00-G99: Diseases of the nervous system G00-G99	Encephalopathy	G93.4	XDH;
E00-E89: Endocrine, nutritional and metabolic diseases	Non-insulin dependent diabetes	E11.9	FFAR1;
C00-D49: Neoplasms	Hormonally-responsive breast cancer	C50	CYP19A1;
N00-N99: Diseases of the genitourinary system	Prostate disease	N42.9	CYP19A1;
E00-E89: Endocrine, nutritional and metabolic diseases	Hyperuricemia	E79.0	XDH;
N00-N99: Diseases of the genitourinary system	Endometriosis	N80	CYP19A1;

Data Section	Select to Download
1. General Info & Plant Usage & Geographical Distribution
2. Human Target Proteins
3. Target Gene Ontology
4. Target KEGG Pathway
5. Related Human Diseases